Cancer BiologyiSciencePeer-reviewed
An integrative proteomics approach identifies tyrosine kinase KIT as a novel therapeutic target for SPINK1-positive prostate cancer.
Nishat Manzar, Umar Khalid Khan, Ayush Goel…·Bushra Ateeq
The paper identifies KIT as a therapeutic target for SPINK1-positive prostate cancer through integrative proteomics and shows KIT inhibition reduces tumor growth and metastasis.
12 citations